Allmox 125 mg/5ml Suspension
PDF Leaflet Revision Date: 02 July 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Infections due to susceptible non-penicillinase producing organisms.
Dosage (summary)
Adults: 125 mg/5 ml every 8 hours; Severe infections: 250 mg/5 ml every 8 hours.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Limited data show no increased risk in pregnancy; excreted in breast milk, may cause diarrhea in infants.
Key Drug Interactions
- Probenecid
- Allopurinol
- Tetracyclines
- Oral anticoagulants
Contraindications
- Hypersensitivity to amoxicillin
- Infectious mononucleosis
Common side effects
- Diarrhoea
- Nausea
- Skin rash
Counselling Points
- Take with plenty of fluids
- Monitor for allergic reactions
- Report any severe diarrhea
Serious warnings
- Serious hypersensitivity reactions
- Convulsions in renal impairment
Important Disclaimer
The Allmox 125 mg/5ml Suspension professional information leaflet below is the property of Innovata Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
